We are monitoring the impact of COVID-19 on Europe Bipolar Disorder Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7946
Share on
Share on

Europe Bipolar Disorder Market Analysis Report – Segmented By Type, Mechanism Of Action, Drug Class and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of EU) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7946
Pages: 145

Europe Bipolar Disorder Market Size (2021 to 2026)

The size of the Bipolar Disorder Market was valued at around USD 0.80 billion in 2021. This value is estimated to grow at a CAGR of 2.12% to reach USD 0.88 billion by 2026.

Growing incidence of bipolar disorders, unmet medical needs, strong pipeline drugs organized by pharmaceutical industries an unhealthy lifestyle of people is majorly increasing the growth of the market in the European region. An estimated 46 million people are diagnosing bipolar disorders globally, in which 52% of males and 48% are female. Technological advancements, a growing number of initiatives taken by the European governments to create awareness among people, and rising government support through funds and investments are positive signals co-operating to develop further. For instance, the introduction of the bipolar disorder phenomena database, sponsored by the National Institute of Mental Health (NIMH), provides full research information regarding the disorder's visible signs and complaints.

Insufficient amenities for bipolar disorder diagnosis, incapable equipment resulting in bipolar disorder, stringent government rules on misrecognition of the disorder, and inadequate equipment resulting in bipolar disorder being written as other personality disorder or depression. Rising adverse side-effects post to the usage of drugs during the treatment of disease, restraining the market growth in the region.

This research report on the European Bipolar Disorder Market has been segmented and sub-segmented into the following categories:

  • By Type: Bipolar I Disorder, Bipolar II Disorder, and Cyclothymic Disorder
  • By Mechanism of Action: Monoamine Oxidase Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotonin-norepinephrine Reuptake Inhibitors, Beta-Blockers, Selective Serotonin Reuptake Inhibitors, and Others
  • By Drug Class: Antianxiety Drugs, Mood Stabilizers, Antidepressant Drugs, Antipsychotic Drugs, and Anticonvulsants
  • By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, and Rest of EU

Regional Analysis:

Europe is next to North America to govern the global bipolar disorder market. It is predicted to hike at a prominent growth rate during the forecast period due to technological advancements, growing awareness associated with bipolar disorder, and healthcare infrastructure advancements. 

Germany and the UK are expected to have notable growth from 2020 to 2025 due to the Y-O-Y increase in bipolar disorders. Technological advancements that have been used in developing genetic research on bipolar disorder and further augmenting the market Growing awareness related to bipolar disorders, a growing number of mergers and acquisitions among drug-producing companies fuel the market region. France, Italy, and Spain hold a significant share in the bipolar disorder market in Europe. 

The increasing awareness about bipolar disorder and the region's developed healthcare infrastructure is expected to be the significant driver of market growth.

Lead players in the market are Gedeon Richter, Indivior, AstraZeneca, Janssen Pharmaceuticals, Lundbeck, Bristol-Myers Squibb, Otsuka Holdings Co. Ltd., Glaxo SmithKline (GSK), Allergan Plc, Pfizer, Inc and AbbVie, Inc

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Method                       

                                5.1.1 Introduction           

                                5.1.2 Genotypic               

                                5.1.3 Proteomics-based               

                                5.1.4 Phenotypic             

                                5.1.5  Y-o-Y Growth Analysis, By Method              

                                5.1.6  Market Attractiveness Analysis, By Method            

                                5.1.7  Market Share Analysis, By Method             

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 F&B            

                                5.2.3 Diagnostic

                                5.2.4 Pharmaceutical     

                                5.2.5 Environmental       

                                5.2.6 Y-o-Y Growth Analysis, By Application         

                                5.2.7 Market Attractiveness Analysis, By Application       

                                5.2.8 Market Share Analysis, By Application        

                5.3 Product                        

                                5.3.1 Introduction           

                                5.3.2 Identification Services        

                                5.3.3 Consumables         

                                5.3.4 Instruments           

                                5.3.5 Y-o-Y Growth Analysis, By Products and Services   

                                5.3.6  Market Attractiveness Analysis, By Products and Services

                                5.3.7  Market Share Analysis, By Products and Services  

                5.4 End User                      

                                5.4.1 Food Manufacturing Industries      

                                5.4.2 Pharmaceutical Companies              

                                5.4.3 Hospitals and Diagnostic Centres   

                                5.4.4 Other End users    

                                5.3.5 Y-o-Y Growth Analysis, By End User             

                                5.3.6  Market Attractiveness Analysis, By End User          

                                5.3.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Method

                                                6.1.3.3 By Application

                                                6.1.3.4 By Product

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Method

                                                6.1.4.3 By Application

                                                6.1.4.4 By Product

                                                6.1.4.5 By End user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Method

                                                6.1.5.3 By Application

                                                6.1.5.4 By Product

                                                6.1.5.5 By End user

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Shimadzu Corporation                           

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Dickinson & Company                            

                8.3 Biolog Inc.                   

                8.4 Merck KGaA                               

                8.5 IEH Laboratories & Consulting Group                              

                8.6 Trivitron Healthcare                

                8.7 Laboratory Corporation of America Holdings                               

                8.8 Thermo Fisher Scientific Inc.                               

                8.9 Bruker Corporation                 

                8.10 Charles River Laboratories                 

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, by  Drug type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Europe Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  2. Europe Bipolar I Disorder Market, By Region, From 2021 to 2026 (USD Million)
  3. Europe Bipolar II Disorder Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Cyclothymic Disorder Market, By Region, From 2021 to 2026 (USD Million)
  5. Europe Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  6. Europe Monoamine Oxidase Inhibitors Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Tricyclic Antidepressants Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Benzodiazepines Market, By Region, From 2021 to 2026 (USD Million)
  9. Europe Serotonin-norepinephrine Reuptake Inhibitors Market, By Region, From 2021 to 2026 (USD Million)
  10. Europe Beta-Blockers Market, By Region, From 2021 to 2026 (USD Million)
  11. Europe Selective Serotonin Reuptake Inhibitors Market, By Region, From 2021 to 2026 (USD Million)
  12. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  13. Europe Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  14. Europe Antianxiety Drugs Market, By Region, From 2021 to 2026 (USD Million)
  15. Europe Mood Stabilizers Market, By Region, From 2021 to 2026 (USD Million)
  16. Europe Antidepressant Drugs Market, By Region, From 2021 to 2026 (USD Million)
  17. Europe Antipsychotic Drugs Market, By Region, From 2021 to 2026 (USD Million)
  18. Europe Anticonvulsants Market, By Region, From 2021 to 2026 (USD Million)
  19. U.K. Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  20. U.K. Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  21. U.K. Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  22. Germany Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  23. Germany Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  24. Germany Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  25. France Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  26. France Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  27. France Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  28. Italy Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  29. Italy Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  30. Italy Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)
  31. Spain Bipolar Disorder Market, By Type, From 2021 to 2026 (USD Million)
  32. Spain Bipolar Disorder Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  33. Spain Bipolar Disorder Market, By Drug Class, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample